ABSTRACT
Shilajit is a herbomineral exudate widely used in traditional medicine and composed mainly of humic substances and low‐molecular‐weight organic constituents. However, the chemical composition and biological relevance of its low‐molecular‐weight fraction remain poorly understood. In this study, sequential fractionation was employed to obtain humins (HM), humic acid (HA), fulvic acid (FA), and a low‐molecular‐weight residual fraction (RF). FTIR analysis supported successful fractionation, with HA and FA exhibiting characteristic humic‐like functional groups, while the RF showed reduced polymeric features consistent with enrichment in smaller organic molecules. Comprehensive chemical profiling using multi‐solvent GC‐MS following derivatization enabled the detection of structurally diverse metabolites. The RF exhibited a broader metabolite profile than whole Shilajit, with 36 low‐molecular‐weight compounds tentatively identified, including phenolics, aromatic acids, esters, flavanol derivatives, and sterol‐related compounds. SEM‐EDS analysis revealed heterogeneous morphology and elemental composition. In silico ADMET predictions suggested favorable gastrointestinal absorption and low predicted toxicity for most compounds. Antimicrobial assays demonstrated stronger antibacterial activity of the RF compared to whole Shilajit, while antifungal activity remained limited. Overall, the findings highlight the biological significance of low‐molecular‐weight constituents in Shilajit.
Keywords: antimicrobial, FTIR, GC‐MS, in silico ADMET, SEM‐EDS, Shilajit
Shilajit was fractionated to obtain humic substances and a residual low‐molecular‐weight fraction to improve analytical characterization. A multitechnique workflow integrating FTIR, SEM‐EDS, and multi‐solvent GC‐MS enabled expanded detection and profiling of low‐molecular‐weight constituents. In silico ADMET analysis and antimicrobial assays were included as supportive functional evaluations. The results highlight the analytical utility of fractionation‐assisted, multi‐solvent GC‐MS for complex herbomineral matrices.

1. Introduction
Shilajit, also known as mumie, asphaltum, mineral pitch, or shilaras, is a blackish‐brown herbomineral exudate found in high‐altitude mountain ranges such as the Himalayas, Hindukush, and Caucasus, as well as other parts of the world [1, 2]. The biogenic formation of Shilajit remains incompletely understood, but several theories suggest that it may result from the humification of plant material, such as species of Trifolium repens, Euphorbia royleana, and other alpine flora together with the contribution of microorganisms. These organic materials, trapped between layers of high‐altitude rocks, undergo slow degradation and microbial transformation over centuries, ultimately giving rise to the complex exudate known as Shilajit [2, 3, 4].
The composition of Shilajit primarily includes humic substances (∼85%), including fulvic acid, humic acid, and humins. The remaining non‐humic fraction (∼15%) comprises various bioactive molecules, including dibenzo‐α‐pyrones, steroids, alkaloids, lipids, and polyphenols, along with essential minerals and trace elements like calcium, sulfur, potassium, chloride, silicon, iron, and more than 80 other ionic micronutrients [1, 5, 6].
Ancient Ayurvedic texts frequently highlight Shilajit, describing it as a highly effective rejuvenator [7]. In modern Ayurvedic pharmacopeias, Shilajit is referred to as Asphaltum punjabianum. It has traditionally been prescribed to enhance strength, vitality, and longevity, and to treat various ailments such as urinary disorders, respiratory diseases, digestive problems, and bone fractures [8]. In Unani and Siddha systems of medicine, Shilajit has also been valued for its anti‐inflammatory, anti‐aging, and restorative properties [9, 10]. Ethnographic and review literature indicate that Shilajit has traditionally been consumed as a dietary adjunct in Himalayan regions, including Nepal, where it is reportedly administered to children mixed with milk or food, and among Sherpa and other high‐altitude communities as part of routine nutritional practices, rather than solely as a medicinal preparation [11, 12]. In recent years, Shilajit has emerged as a trending supplement within the fitness industry, with athletes and bodybuilders utilizing it for its claimed testosterone‐enhancing and adaptogenic benefits that support endurance and muscle recovery.
Drawing from traditional use, modern studies have explored the biological relevance of Shilajit and its constituents, attributing reported antioxidant, anti‐inflammatory, immunomodulatory, and metabolic effects primarily to humic substances, fulvic acids, dibenzo‐α‐pyrones, trace minerals, and polyphenolic compounds [8, 9, 13]. While both preclinical and limited clinical investigations suggest potential bioactivity, outcomes vary considerably with formulation, processing, and study design, and many reports are constrained by small sample sizes and limited standardization [14, 15]. Consequently, despite growing biological interest, clear composition‐function relationships remain poorly defined, underscoring the need for rigorous analytical characterization to support meaningful biological interpretation [8].
Beyond its antioxidant and adaptogenic roles, Shilajit has shown direct antimicrobial activity against a range of bacterial and fungal pathogens. Several in vitro studies report inhibitory effects of crude and processed Shilajit extracts against organisms such as Staphylococcus aureus, Escherichia coli, Candida albicans, and other clinically relevant strains, although potency varies with preparation and assay method [16, 17]. Comparative reports additionally suggest that processing and extraction method (e.g., UV treatment, solvent system) influence antimicrobial outcomes, implying that composition and bioavailability are critical determinants of activity [17, 18]. Although humic/fulvic fractions show bioactivity in antiviral and other assays, direct fraction‐wise attribution of antibacterial and antifungal effects remains limited, underscoring the need for studies that couple fractionation with chemical profiling and functional testing.
The biological significance of Shilajit rests on a broad pharmacological spectrum, especially antioxidant, anti‐inflammatory, and bone‐modulating effects, while clinical significance is suggested by preliminary trials in men's hormonal health, bone preservation in women, and fatigue modulation. Yet, its complete chemical composition remains insufficiently characterized, and clinical evaluation of its efficacy and safety is still limited. Despite these gaps, recent years have witnessed a growing trend of Shilajit use among athletes, bodybuilders, and fitness enthusiasts for its purported testosterone‐boosting and performance‐enhancing properties, leading to increasing consumption among the younger population. This unregulated and unsupervised use raises concerns regarding purity, dosing consistency, and potential adverse effects, underscoring the need for rigorous pharmacological and toxicological assessment. However, the existing body of evidence remains limited, and further well‐designed, large‐scale randomized controlled trials are essential. Addressing concerns such as bioavailability, standardization of extract (especially fulvic/humic content), potential heavy‐metal contamination, and mechanistic pathways will be crucial for advancing Shilajit from traditional lore to a credible therapeutic agent.
In the present study, Shilajit was fractionated into humins (HM), humic acid (HA), fulvic acid (FA), and a low‐molecular‐weight residual fraction (RF) to elucidate their distinct chemical and biological attributes. These fractions were characterized using FTIR. Particular emphasis was placed on the RF because it is enriched in low‐molecular‐weight non‐humic constituents that remain poorly characterized in Shilajit. In addition to whole Shilajit, RF was investigated to facilitate improved characterization of these compounds, representing an analytical approach not previously reported for Shilajit. Surface morphology, elemental composition, and the pharmacokinetic characteristics of the identified constituents were also evaluated to provide a more comprehensive understanding of Shilajit and its fractions. The biological relevance of the identified chemical constituents was further evaluated through in vitro antimicrobial screening. These organisms were intentionally selected to represent distinct microbial categories with both clinical and environmental relevance, while also addressing microbial groups that remain comparatively less explored in studies involving Shilajit fractions. As a novel contribution, this study evaluated the antimicrobial potential of RF, the low‐molecular‐weight fraction remaining after removal of humic substances, which has not previously been investigated for antimicrobial activity. Assessing both the whole extract and RF broadens the understanding of Shilajit's antimicrobial spectrum and strengthens the link between its chemical complexity and biological activity.
2. Materials and Methods
2.1. Chemicals and Reagents
Commercial Himalayan Shilajit resin was procured from Upakarma Ayurveda Pvt. Ltd., India, through commercial e‐commerce platform. Detailed product specifications and batch information are provided in Table S1. The material was characterized using FTIR, and the spectra matched previously reported profiles of authentic Shilajit [1, 19], confirming its identity. The product was used in its marketed form without further purification and stored at room temperature (25°C) until use. Methanol, ethyl acetate, hexane, and acetonitrile used for GC‐MS analysis were of HPLC grade (≥ 99.8% purity). Other chemicals and reagents, including HCl, NaOH, ethanol, and the derivatizing agent BSTFA:TMCS [N,O‐bis(trimethylsilyl) trifluoroacetamide: trimethylchlorosilane] (99:1), were of analytical reagent (AR) grade and procured from Merck Life Sciences Pvt. Ltd. (India) and SRL Pvt. Ltd. (India). For antimicrobial assays, Nutrient Agar (NA) and agar‐agar were obtained from HiMedia Laboratories (Mumbai, India) and were used to prepare NA agar plates following standard procedures. Standard antibacterial agent ciprofloxacin and antifungal agent itraconazole (Sigma–Aldrich, USA) were used as the positive control. Shilajit and the RF fraction were dissolved to prepare a 1 mg/mL stock solution, from which all working concentrations used in the antibacterial and antifungal assays were obtained by appropriate dilution.
2.2. Fractionation of Shilajit
The extraction of HM and HA was carried out using a modified procedure based on previous literature [2]. Shilajit (15 g) was dissolved in 100 mL of 0.5 M NaOH and shaken for 10 h at room temperature. The suspension was centrifuged at 5000 rpm for 30 min to remove insoluble HM. The supernatant was acidified to pH 1 using concentrated HCl, leading to precipitation of HA. The precipitate was collected by centrifugation at 10 000 rpm for 30 min and stored as the HA. The remaining supernatant was neutralized with 0.5 M NaOH and treated with activated charcoal (1 g). The adsorption of fulvic acids onto charcoal occurs mainly through hydrogen bonding, hydrophobic interactions, and π–π stacking between aromatic groups [20]. The mixture was stirred for 45 min, followed by centrifugation at 10 000 rpm for 30 min. The resulting charcoal pellet containing adsorbed fulvic acid was subjected to desorption in absolute methanol under stirring for 30 min. Methanol was evaporated to obtain the FA. The final supernatant, enriched with low‐molecular‐weight non‐humic compounds, was collected as the RF for GC‐MS analysis.
2.3. Fourier‐Transform Infrared (FTIR) Spectroscopy
FTIR spectra of Shilajit fractions were recorded using a Nicolet 5700 spectrophotometer (Thermo Scientific, USA). Samples were prepared by thoroughly mixing 1 mg of dried fraction with 100 mg of spectroscopic‐grade KBr (Sigma–Aldrich, USA), followed by pelletization under hydraulic pressure as described previously by [21]. The pellets were dried in an oven prior to measurement and then placed in the FTIR sample holder. Spectra were collected in the mid‐infrared region (4000–400 cm− 1) and processed using OMNIC software for baseline correction and spectral interpretation.
2.4. Gas Chromatography Mass Spectrometry (GC‐MS)
Humic acid (HA), fulvic acid (FA), and humins (HM) are predominantly high‐molecular‐weight polymeric materials that are poorly suited for GC‐MS analysis and may interfere with the detection of low‐molecular‐weight constituents. Therefore, GC‐MS analysis was focused on whole Shilajit and the residual fraction (RF), which remains after removal of the major humic substances. Whole Shilajit was analyzed using multiple solvent systems, whereas RF was specifically evaluated to facilitate characterization of low‐molecular‐weight compounds.
GC‐MS analysis was performed on a Shimadzu GC‐MS‐TQ8040 NX system operated in full‐scan EI mode equipped with a Nexis GC‐2030 gas chromatograph, and an AOC‐20i Plus autosampler (Shimadzu Corp., Kyoto, Japan). Chromatographic separation was achieved on a Shimadzu SH‐I‐5Sil MS fused silica capillary column (30 m × 0.25 mm i.d., 0.25 µm film thickness; 5% phenyl‐95% dimethylpolysiloxane stationary phase), an MS‐grade low‐bleed column suitable for analyzing volatile and semi‐volatile organic compounds [22].
Samples dissolved in acetonitrile were derivatized with BSTFA:TMCS (99:1, v/v) and incubated at 60°C for 45 min prior to injection to increase the volatility and thermal stability of polar compounds [23]. while extracts prepared in methanol, hexane, and ethyl acetate were injected directly without derivatization. The injection volume was 1 µL, with a split ratio of 1:20. Helium was used as the carrier gas at a flow rate of 1.0 mL/min.
The GC oven program was set as follows: initial temperature 50°C, increased at 10°C/min to 230°C, then ramped at 20°C/min to 350°C and held for 5 min. The injector temperature was maintained at 250°C and the interface temperature at 280°C. Electron impact ionization was performed at 70 eV, and the detector voltage was set at 0.9 kV. Baseline correction and preliminary peak detection were performed using OpenChrom (Lablicate edition). Deconvolution of co‐eluting peaks was carried out using AMDIS (NIST) to improve spectral purity. The resulting spectra were matched against NIST23 and MoNA EI spectral libraries for tentative compound identification.
2.5. Scanning Electron Microscope‐Energy Dispersive X‐Ray Spectroscopy (SEM‐EDS)
Surface morphology and elemental composition of dry Shilajit were analyzed using a JEOL JSM‐IT500 scanning electron microscope (JEOL Ltd., Tokyo, Japan) equipped with an EDS detector. Samples were mounted on aluminum stubs using double‐sided carbon adhesive tape. SEM observations were carried out under high vacuum at an accelerating voltage of 15 kV, with magnifications ranging from 500x to 10 000x [21]. Elemental analysis was performed using the EDS system at the same accelerating voltage, and spectra were processed with the instrument's analysis software for semi‐quantitative determination of elemental composition.
2.6. In Silico ADMET Analysis
The pharmacokinetic and drug‐likeness properties of compounds identified from GC‐MS analysis of Shilajit were evaluated using SwissADME [24]. The chemical structures of the selected molecules were retrieved in SMILES format from the PubChem database. Each molecule was analyzed for ADMET properties, including absorption, distribution, metabolism, excretion, and toxicity. Drug‐likeness was assessed based on Lipinski's rule of five and related molecular descriptors, such as molecular weight, hydrogen bond donors and acceptors, and lipophilicity (LogP). Additionally, the BOILED‐Egg model implemented in SwissADME was used to visualize passive gastrointestinal absorption and blood‐brain barrier penetration, providing a predictive assessment of the compounds’ pharmacokinetic suitability for potential therapeutic applications.
2.7. In Vitro Antibacterial Activity
The antibacterial potential of Shilajit was evaluated by the agar well diffusion method, following standard procedures described by [25]. Agar media (HiMedia) was prepared by dissolving Nutrient agar (NA) and agar‐agar in distilled water. The dissolved medium was autoclaved at 15 lbs pressure at 121°C for 15 min. Fresh overnight cultures of Pseudomonas aeruginosa (ATCC 27853) and Bacillus cereus (ATCC 11778) were adjusted to 0.5 McFarland turbidity (1.5 × 108 CFU/mL) and uniformly spread onto agar plates using sterile cotton swabs. The bacterial strains were selected to represent both Gram‐positive and Gram‐negative bacteria of clinical relevance. Bacillus cereus (ATCC 11778) was included as a representative Gram‐positive bacterium associated with foodborne infections [26], whereas Pseudomonas aeruginosa (ATCC 27853) was selected as a Gram‐negative pathogen with strong biofilm‐forming capacity and intrinsic antimicrobial resistance [27]. Wells (6 mm diameter) were made aseptically in the agar, and test samples at 30, 60, 90, 120 µg concentrations were loaded into each well. Ciprofloxacin (30 µg/well) served as the positive control. Plates were incubated at 37°C for 24 h, after which the antibacterial activity was assessed by measuring the diameter of the inhibition zones (mm) around each well. The MIC of Shilajit and RF was determined by the broth microdilution method following CLSI guidelines [28]. Different concentrations of the samples were prepared in suitable broth media, inoculated with standardized microbial suspensions, and incubated at 37°C for 24 h. Initial MIC evaluation was performed at concentrations of 128, 256, and 512 µg/mL, along with 1 mg/mL. In cases where no visible inhibition was observed at lower concentrations, higher concentrations up to 3 mg/mL were further evaluated. MIC was defined as the lowest concentration showing no visible microbial growth.
2.8. In Vitro Antifungal Activity
The antifungal activity of Shilajit fractions was tested against Aspergillus niger (ATCC 16888) and Aspergillus fumigatus (ATCC 204305) using the agar well diffusion method on Sabouraud Dextrose Agar (SDA) plates [29]. Fresh fungal spore suspensions (106 spores/mL) were inoculated on SDA, and wells (6 mm diameter) and test samples at 30, 60, 90, 120 µg concentrations were loaded into each well. Itraconazole (30 µg/well) was used as the positive control. Plates were incubated at 28°C for 48 h, and zones of inhibition (mm) were measured around each well. The antifungal MIC of Shilajit and RF was determined by the broth microdilution method in accordance with CLSI guidelines [28]. Different concentrations of the samples were prepared in RPMI‐1640 medium, inoculated with standardized fungal suspensions, and incubated at 28°C–30°C for 48 h. Initial MIC evaluation was performed at concentrations of 128, 256, and 512 µg/mL, along with 1 mg/mL. In cases where no visible inhibition was observed at lower concentrations, higher concentrations up to 3 mg/mL were further evaluated. MIC was defined as the lowest concentration showing no visible fungal growth.
2.9. Statistical Analysis
Data analysis was conducted using GraphPad Prism (version 10.4; GraphPad Software Inc., San Diego, CA, USA). Antimicrobial activity experiments were performed in triplicates (n = 3). Data are presented as mean ± standard deviation (SD). Statistical significance between groups was evaluated using one‐way ANOVA followed by Tukey's post‐hoc test. A p‐value < 0.05 was considered statistically significant. Graphs were generated in GraphPad Prism, and significance levels are indicated by star annotations: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).
3. Results and Discussion
3.1. Fractionation
Shilajit was successfully fractionated into HM, HA, FA, and RF using sequential alkaline extraction and acid precipitation. Each fraction exhibited distinct differences in color and solubility. Shilajit appears as a thick, black, resinous material (Figure 1a). HM formed the insoluble residue and appeared pitch black (Figure 1b), HA precipitated as a dark brown solid under acidic conditions (Figure 1c), FA remained as a yellow‐brown soluble fraction (Figure 1d), and RF represented the remaining material after removal of humic and fulvic acids. The approximate recovered yields of the major fractions were HM (∼15%), HA (∼20%), FA (∼60%), and RF (∼5%). These values represent approximate recovered dry fraction yields obtained following the multistep fractionation procedure.
FIGURE 1.

Humic substances (HS) isolated from Shilajit by fractionation: (a) Shilajit (b) Humin, (c) Humic acid, and (d) Fulvic acid.
3.2. FTIR Characterization
FTIR spectra of crude Shilajit and its derived fractions (Figure 2a–e) revealed distinct functional group signatures characteristic of each separation product. Crude Shilajit (Figure 2a) displayed a broad O─H stretching band around 3375 cm− 1, aliphatic C─H vibrations near 2965–2930 cm− 1, C═C aromatic stretching band at 1595 cm− 1 and a prominent C─O band at 1049 cm− 1. Humins (Figure 2b) showed similar O─H and aromatic C═C bands but with additional intense peaks in the 870–555 cm− 1 fingerprint region. Humic acid (Figure 2c) exhibited strong O─H stretching (∼3446 cm− 1), a well defined carboxyl C═O peak (∼1722 cm− 1), and aromatic C═C absorption at ∼1628 cm− 1. Fulvic acid (Figure 2d) showed broader O─H bands (3300–3400 cm− 1), carbonyl stretching at ∼1701 cm− 1, and C─O vibrations in the 1214–1040 cm− 1 range. The residual fraction (Figure 2e) retained O─H (∼3440 cm− 1), C═O (∼1704 cm− 1), and aromatic C═C (∼1515 cm− 1) bands, consistent with standard FTIR functional group assignments [30]. Collectively, the spectra confirm successful fractionation, with each fraction retaining a distinct set of functional groups corresponding to its chemical composition.
FIGURE 2.

FTIR spectra of (a) Shilajit, (b) Humins, (c) Humic acid, (d) Fulvic acid, and (e) Residual Fraction, showing characteristic functional groups and peak distributions for each fraction.
3.3. GC‐MS Analysis
The GC‐MS analysis of Shilajit in different solvents (Figure S1a–e) revealed a diverse chemical profile depending on solvent polarity and derivatization, with the identified compounds summarized in Tables 1, 2, 3, 4, 5. Methanol extracts (Figure S1a and Table 1) were rich in simple aromatics such as benzoic acid, benzamide, morin (flavonoids), and fenchone (monoterpenoid), while ethyl acetate (Figure S1b and Table 2) yielded phenolics (benzoic acid, 4‐hydroxybenzoic acid), aldehydes (syringaldehyde), fatty acids (oleic acid), and terpenoids (isopulegol). Hexane (Figure S1c and Table 3) primarily extracted fatty acids (palmitic, stearic, oleic), aliphatic acids (succinic, diethyl succinate), and phenolic acids (3‐hydroxybenzoic). Acetonitrile extracts after BSTFA+TMCS derivatization (Figure S1d and Table 4) revealed more complex metabolites, including sterol (Stigmasterol), alkaloidal (6‐methoxyquinoline), sesquiterpenoids (cryptomeridiol, germacrone), gallic acid, and monoterpenoids (isopulegol). The derivatized low‐molecular‐weight residual fraction (RF) (Figure S1e and Table 5) contained simple esters and acids (allyl acetate, phenyl acetate, succinic anhydride), phenolics (gallic acid), flavanols (epigallocatechin), sterols (campesterol derivatives), and organophosphorus compounds (triphenylphosphine oxide). Common compounds such as benzoic acid, gallic acid, and long‐chain fatty acids appeared in multiple extracts, while unique molecules in each solvent highlighted the complementary nature of multisolvent extraction and derivatization, providing a comprehensive metabolic profile of Shilajit.
TABLE 1.
Compounds identified in the methanol‐soluble fraction of Shilajit by GC‐MS analysis.
| Peak no. | Retention time (RT) | Name of the compound | Molecular formula | M. Weight |
|---|---|---|---|---|
| 1. | 2.32 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 2. | 2.60 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 3. | 2.90 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 4. | 3.45 | Benzamide | C7H7NO | 121.14 g/mol |
| 5. | 3.82 | Morin | C15H10O7 | 302.24 g/mol |
| 6. | 5.86 | Fenchone | C10H16O | 152.23 g/mol |
TABLE 2.
Compounds identified in ethyl acetate‐soluble fraction of Shilajit by GC‐MS analysis.
| Peak no. | Retention time (RT) | Name of the compound | Molecular formula | M. Weight |
|---|---|---|---|---|
| 1. | 7.12 | 1,1,4,5,6‐pentamethyl(2,3‐dihydroindene) | C14H20 | 188.31 g/mol |
| 2. | 7.68 | Allyl acetate | C5H8O2 | 100.12 g/mol |
| 3. | 9.90 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 4. | 14.22 | 4‐hydroxy benzoic acid | C7H6O3 | 138.12 g/mol |
| 5. | 15.51 | 2,3,4,5‐tetramethyl‐hexa‐1,4,diene | C10H18 | 138.25 g/mol |
| 6. | 18.45 | Oleic acid | C18H34O2 | 282.46 g/mol |
| 7. | 21.82 | Syringaldehyde | C9H10O4 | 182.17 g/mol |
| 8. | 32.9 | Isopulegol | C10H18O | 154.25 g/mol |
TABLE 3.
Compounds identified in hexane‐soluble fraction of Shilajit by GC‐MS analysis.
| Peak no. | Retention time (RT) | Name of the compound | Molecular formula | M. Weight |
|---|---|---|---|---|
| 1. | 4.93 | 4‐isopropylbenzoic acid | C10H12O2 | 164.20 g/mol |
| 2. | 8.01 | Lactic acid | C3H6O3 | 90.08 g/mol |
| 3. | 8.23 | Glycolic acid | C2H4O3 | 76.05 g/mol |
| 4. | 10.90 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 5. | 11.83 | Succinic acid | C4H6O4 | 118.09 g/mol |
| 6. | 15.14 | 3‐hydroxy benzoic acid | C7H6O3 | 138.12 g/mol |
| 7. | 15.72 | Diethyl succinate | C8H14O4 | 174.20 g/mol |
| 8. | 15.86 | 3‐hydroxy phenylacetic acid | C8H8O3 | 152.15 g/mol |
| 9. | 17.69 | 3,4‐dihydroxy mandelic acid | C8H8O5 | 184.15 g/mol |
| 10. | 21.5 | Palmate | C16H32O2 | 256.43 g/mol |
| 11. | 24.55 | Steric acid | C18H36O2 | 284.48 g/mol |
TABLE 4.
Compounds identified in acetonitrile‐soluble fraction of Shilajit (derivatized by BSTFA+TMCS) by GC‐MS analysis.
| Peak no. | Retention time (RT) | Name of the compound | Molecular formula | M. Weight |
|---|---|---|---|---|
| 1. | 9.98 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 2. | 14.01 | Stigmasterol | C29H48O | 412.7 g/mol |
| 3. | 14.46 | 6‐methoxy quinoline | C10H9NO | 159.19 g/mol |
| 4. | 14.92 | Gallic acid | C7H6O5 | 170.12 g/mol |
| 5. | 15.45 | 6‐methoxy quinoline | C10H9NO | 159.19 g/mol |
| 6. | 18.46 | Cryptomeridiol | C15H26O2 | 238.37 g/mol |
| 7. | 40.92 | Isopulegol | C10H18O | 154.25 g/mol |
| 8. | 41.82 | Germacrone | C15H22O | 218.33 g/mol |
TABLE 5.
Compounds identified in acetonitrile‐soluble residual fraction of Shilajit (derivatized by BSTFA+TMCS) by GC‐MS analysis.
| Peak no. | Retention time (RT) | Name of the compound | Molecular formula | M. Weight |
|---|---|---|---|---|
| 1. | 7.89 | Allyl acetate | C5H8O2 | 100.12 g/mol |
| 2. | 8.45 | Succinic anhydride | C4H4O3 | 100.07 g/mol |
| 3. | 10.71 | Benzoic acid | C7H6O2 | 122.12 g/mol |
| 4. | 11.62 | 1‐butyl, 1‐methyl‐hydrazine | C5H14N2 | 102.18 g/mol |
| 5. | 12.02 | Phenyl acetate | C8H8O2 | 136.15 g/mol |
| 6. | 14.15 | Methyl adipic acid (Morin) | C7H12O4 | 160.17 g/mol |
| 7. | 16.09 | Epigallocatechin | C15H14O7 | 306.27 g/mol |
| 8. | 16.60 | Gallic acid | C7H6O5 | 170.12 g/mol |
| 9. | 20.01 | Palmitic acid | C16H32O2 | 256.43 g/mol |
| 10. | 21.93 | 2‐(coumarin‐3‐yl)‐acetate | C11H8O4 | 204.18 g/mol |
| 11. | 25.51 | Triphenylphosphine oxide | C18H15OP | 278.29 g/mol |
| 12. | 28.02 | Campesterol, propionate | C28H48O | 400.68g/mol |
3.4. SEM‐EDS Analysis
SEM micrographs of dry Shilajit sample (Figure 3a–d) revealed irregular, fractured particles with sharp edges and heterogeneous morphology, ranging from aggregated clusters at lower magnifications to layered and porous surfaces at higher magnifications (Figure 3d). This morphology reflects the multiphase nature of Shilajit, where both organic and inorganic components coexist. EDS analysis (Figure 4 and Table 6) confirmed carbon and oxygen as major elements, consistent with organic acids and polyphenolic compounds, along with trace minerals such as Si, Al, Fe, and Ca, indicative of mineral inclusions. In addition, minor peaks of elements such as Mg, K, Na, and S were also observed, suggesting the presence of essential micronutrients. The relative abundance of C and O indicated that the organic fraction dominates, whereas the mineral elements support its inorganic matrix. These findings further emphasize that Shilajit acts as a natural reservoir of bioactive organic molecules and mineral micronutrients, with its microstructure facilitating the binding of both organic functional groups and mineral ions within a single heterogeneous matrix.
FIGURE 3.

SEM micrograph showing the surface texture of dry Shilajit at various magnification; 750x (a), 1000x (b), 5000x (c) and 10 000x (d).
FIGURE 4.

SEM‐EDS spectrum of Shilajit indicating the presence of major elements including C and O, along with trace levels of Na, Mg, Si, S, Cl, K, and Ca. The labeled K‐shell emission peaks confirm the elemental composition of the analyzed region.
TABLE 6.
Elemental composition of Shilajit determined by SEM‐EDS analysis.
| Element | Line | Mass% | Atom% |
|---|---|---|---|
| C | K | 45.36 ± 0.16 | 56.90 ± 0.20 |
| O | K | 36.30 ± 0.32 | 34.19 ± 0.30 |
| Na | K | 2.31 ± 0.05 | 1.51 ± 0.04 |
| Mg | K | 3.73 ± 0.06 | 2.31 ± 0.03 |
| Si | K | 0.95 ± 0.03 | 0.51 ± 0.02 |
| S | K | 1.83 ± 0.03 | 0.86 ± 0.02 |
| Cl | K | 1.42 ± 0.03 | 0.60 ± 0.01 |
| K | K | 6.34 ± 0.07 | 2.44 ± 0.03 |
| Ca | K | 1.76 ± 0.05 | 0.66 ± 0.02 |
| Total | 100 | 100 |
3.5. ADMET Profiling
The ADMET properties of 36 compounds identified from Shilajit and its fractions were evaluated using in silico prediction tools. Physicochemical descriptors such as molecular weight, TPSA, and lipophilicity (LogP) were within acceptable ranges for most compounds, indicating compliance with drug‐likeness filters. Most molecules followed Lipinski's rule of five with zero or minimal violations and showed favorable bioavailability scores (0.55–0.85). Predicted solubility values varied, with small phenolic acids such as gallic acid, 4‐hydroxybenzoic acid, and lactic acid showing high aqueous solubility, whereas larger lipophilic molecules like oleic acid, palmitic acid, and campesterol propionate exhibited poor solubility.
Pharmacokinetic predictions revealed that GI absorption was high for most compounds, though a few (e.g., morin, epigallocatechin, and campesterol propionate) showed limited absorption potential. BOILED‐Egg model analysis (Figure 5) provided a visual confirmation of these predictions; clearly distinguishing compounds located within the “yolk” region (likely to cross the blood‐brain barrier) and the “white” region (likely to show high gastrointestinal absorption). Small lipophilic molecules such as benzoic acid, benzamide, fenchone, and isopulegol appeared in the yolk, indicating BBB penetration, while most polyphenolic compounds clustered in the white zone, reflecting strong intestinal absorption but limited CNS penetration.
FIGURE 5.

BOILED‐Egg model of 36 Shilajit‐derived compounds showing predicted gastrointestinal absorption and blood‐brain barrier permeability.
Interaction with metabolic enzymes was selective, only a few molecules (oleic acid, palmitic acid, cryptomeridiol, triphenylphosphine oxide) showed potential CYP450 inhibition, while most did not inhibit major isoforms, suggesting a lower risk of metabolic interference. Importantly, no compound exhibited significant PAINS alerts, and synthetic accessibility scores indicated that most molecules were of low to moderate synthetic complexity. Overall, the ADMET analysis highlights that while Shilajit‐derived compounds vary in solubility and permeability, several candidates demonstrate favorable drug‐like characteristics, aligning with their potential therapeutic relevance. The complete ADMET parameters for all 36 identified compounds are provided in the Supporting Information (Table S2).
3.6. In Vitro Antibacterial Activity
The antibacterial activity of the test samples RF and Shilajit was evaluated against Pseudomonas aeruginosa and Bacillus cereus using the agar well diffusion method and MIC assays. The results are expressed as diameter of the inhibition zones (mm) at different concentrations (30, 60, 90, and 120 µg/well), compared with a standard antibiotic Ciprofloxacin (30 µg/well).
3.6.1. Residual Fraction (RF)
The sample RF exhibited significant antibacterial activity against both P. aeruginosa and B. cereus. For P. aeruginosa, the inhibition zone increased progressively from 25 mm at 30 µg to 34 mm at 120 µg, compared with 40 mm for the standard (Ciprofloxacin). Similarly, against B. cereus, inhibition zones ranged from 24 mm at 30 µg to 32 mm at 120 µg, while the standard (Ciprofloxacin) showed 43 mm inhibition. The corresponding inhibition zone data are visually represented in graphical form in Figure 6. These results indicate a clear dose‐dependent increase in antibacterial activity, suggesting good efficacy of RF against both gram‐negative and gram‐positive organisms. Quantitative evaluation by broth microdilution revealed MIC values of 256 µg/mL for P. aeruginosa and 128 µg/mL for B. cereus (Table 7).
FIGURE 6.

Antibacterial activity of RF against Pseudomonas aeruginosa (a) and Bacillus cereus (b), expressed as inhibition zone diameters (mm) at concentrations 30‐120 µg/well. Ciprofloxacin (30 µg/well) was used as the standard positive control. Data are presented as mean ± SD (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
TABLE 7.
Minimum inhibitory concentration (MIC) values of the residual fraction and whole Shilajit against selected bacterial and fungal strains.
| Residual fraction | Shilajit | |
|---|---|---|
| P. aeruginosa | 256 µg | — |
| B. cereus | 128 µg | 2 mg |
| A. niger | 2 mg | 2 mg |
| A. fumigatus | — | — |
3.6.2. Shilajit
The sample Shilajit showed moderate antibacterial activity compared to the standard. For P. aeruginosa, inhibition zones increased from 14 mm at 30 µg to 21 mm at 120 µg, whereas the standard exhibited 40 mm. For B. cereus, inhibition zones increased from 12 mm at 30 µg to 23 mm at 120 µg, compared with 43 mm for the standard. All measured inhibition zone values are presented in graphical form in Figure 7. Although the activity was lower than the reference drug, the concentration‐dependent increase indicates that Shilajit possesses measurable antibacterial potential, particularly against B. cereus at higher concentrations. Comparatively, RF demonstrated stronger antibacterial activity than Shilajit against both tested organisms. The inhibition zones of RF were consistently larger at all concentrations, suggesting a higher content of bioactive antibacterial constituents in RF. Quantitative evaluation by broth microdilution showed an MIC value of 2 mg/mL for Shilajit against B. cereus, whereas no MIC was observed for P. aeruginosa within the tested concentration range (Table 7).
FIGURE 7.

Antibacterial activity of Shilajit against Pseudomonas aeruginosa (a) and Bacillus cereus (b), expressed as inhibition zone diameters (mm) at concentrations 30‐120 µg/well. Ciprofloxacin (30 µg/well) was used as the standard positive control. Data are presented as mean ± SD (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
3.7. In Vitro Antifungal Activity
The antifungal potential of the samples RF and Shilajit was evaluated against Aspergillus niger and Aspergillus fumigatus using the agar well diffusion method and MIC asssay. The zone of inhibition was measured in millimeters (mm) for different concentrations (30, 60, 90, and 120 µg/well) and compared with a standard Itraconazole (30 µg/well).
3.7.1. Residual Fraction (RF)
The RF extract exhibited weak antifungal activity compared to the standard against A. niger, the inhibition zone increased slightly from 7 mm at 30 µg to 15 mm at 120 µg, whereas the standard antifungal agent produced a 31 mm zone. For A. fumigatus, the inhibition zone ranged from 7 mm at 30 µg to 17 mm at 120 µg, compared with 32 mm for the standard. The corresponding inhibition zone data are visually represented in graphical form in Figure 8. Although growth inhibition increased with concentration, the overall activity remained mild, suggesting limited antifungal constituents in the RF extract. Broth microdilution analysis showed an MIC value of 2 mg/mL for RF against both A. niger and A. fumigatus (Table 7).
FIGURE 8.

Antifungal activity of Residual Fraction (RF) against Aspergillus niger (a) and Aspergillus fumigatus (b), expressed as inhibition zone diameters (mm) at concentrations 30‐120 µg/mL. Itraconazole (30 µg/well) was used as the standard positive control. Data are presented as mean ± SD (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
3.7.2. Shilajit
The Shilajit extract showed moderate antifungal activity, with a clearer dose‐dependent effect against A. niger, inhibition zones increased from 5 mm at 30 µg to 12 mm at 120 µg, whereas the standard antifungal agent produced a 31 mm zone. For A. fumigatus, the inhibition increased from 8 mm at 30 µg to 17 mm at 120 µg where standard shows 32 mm. The corresponding inhibition zone data are visually represented in graphical form in Figure 9. The results suggest that Shilajit contains bioactive compounds with potential antifungal properties, particularly effective against A. fumigatus. However, no MIC was observed for Shilajit against either fungal strain within the tested concentration range.
FIGURE 9.

Antifungal activity of Shilajit against Aspergillus niger (a) and Aspergillus fumigatus (b), expressed as inhibition zone diameters (mm) at concentrations 30‐120 µg/mL. Itraconazole (30 µg/well) was used as the standard positive control. Data are presented as mean ± SD (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Comparative analysis shows that Shilajit demonstrated higher antifungal activity than RF at all concentrations and against both fungal strains. The activity of both extracts increased with concentration, showing a dose‐dependent trend, but neither matched the inhibition levels of the standard drug. Based on the observed MIC values and inhibition zones, the antibacterial activity of the residual fraction (RF) against B. cereus and P. aeruginosa may be considered moderate, whereas the activity of whole Shilajit and the antifungal activity of both samples may be regarded as weak. The comparatively lower MIC values observed for RF indicate enhanced antibacterial potency following fractionation. Representative photographic images of antibacterial and antifungal agar diffusion assays are provided in the Supporting Information (Figures S2–S5).
4. Discussion
This study systematically fractionated Himalayan Shilajit into humins, humic acid, fulvic acid, and a low‐molecular‐weight residual fraction. Comprehensive physicochemical (FTIR, GC‐MS, SEM‐EDS), computational (ADMET), and microbiological assays were then integrated to delineate the relationship between chemical constituents and biological effects. Fractionation yielded chemically distinct fractions (HA, FA, HM, RF) with predictable functional‐group distributions, HA enriched in carboxylated aromatics, FA is more oxygenated/polar, HM dominated by condensed aromatics and mineral associations, GC‐MS profiling shows mixture of low‐molecular‐weight organics, fatty acids, and sterol derivatives, it consistently identified benzoic acid as a major constituent across all solvent extracts, suggesting its strong association with Shilajit's core matrix and potential contribution to bioactivity. Elemental analysis (EDX) confirmed an organic rich composition with trace minerals. In silico ADMET indicated several low‐molecular‐weight components with favorable drug‐like properties (high GI absorption, acceptable bioavailability scores), but also highlighted solubility/permeation variability across compounds. These integrated results suggest that the biological activity of Shilajit derives from an ensemble of small polar phenolics and lipophilic components distributed across fractions, rather than a single dominant compound. In bioassays, RF displayed the most pronounced antibacterial effect, whereas the complete Shilajit sample exhibited comparatively higher antifungal activity.
The FTIR spectra of the isolated HM, HA, FA, and RF exhibited characteristic absorption bands corresponding to the major functional groups typically present in humic substances. The presence of hydroxyl, carbonyl, carboxylic, aromatic, and aliphatic groups confirm the complex polyfunctional nature of the Shilajit derived organic matter. The Shilajit fractions isolated in this study showed FTIR features similar to those of humic substances from soil, peat, compost, and lignite. The FTIR profile of the HA fraction (Figure 2c) obtained in this study closely matches with previously reported spectra for humic acids, consistent with those described by [31, 32, 33], showing the characteristic broad O–H stretching band (∼3400 cm− 1), aliphatic C–H stretching at 2933 cm− 1, and the strong C═O band near 1720 cm− 1. The FTIR pattern of the FA fraction obtained (Figure 2d) also aligns closely with previously reported spectra of fulvic acids from terrestrial and aquatic sources, which similarly exhibit pronounced bands in the 1200–1000 cm− 1 region attributed to C–O and C–O–C stretching of polysaccharides and alcohols, indicating a higher degree of oxidation and hydrophilicity [34, 35]. The more intense aromatic C═C stretching near 1620–1640 cm− 1 in HA (Figure 2c) aligns with previous findings for mature humic acids from lignite and forest soils, suggesting advanced aromatic condensation and humification [36]. In contrast, the HM fraction exhibited stronger C‐H stretching (2920‐2850 cm− 1) and weaker oxygenated peaks (Figure 2b), consistent with mineral‐bound or polymerized aliphatic structures, as reported for sedimentary humin [37]. The FTIR spectrum of the RF fraction (Figure 2e) showed only distinct, sharp bands with the absence of broad polymer‐associated peaks, indicating that this fraction is composed predominantly of low‐molecular‐weight compounds and is largely devoid of humic or fulvic polymers. Such comparisons highlight that the Shilajit‐derived fractions share a molecular signature analogous to other naturally humified materials, supporting their formation through prolonged microbial and oxidative transformation of plant and resinous precursors. The relative intensity of oxygen‐containing functional groups (carboxyl, hydroxyl, and carbonyl) in FA and HA indicates a higher oxidation degree and explains their solubility and reactivity compared to HM.
The functional groups identified also have direct implications for the biological activity of these fractions. The abundance of carboxylic and phenolic groups in HA and FA contributes to their metal‐chelating, antioxidant, and antimicrobial properties, as these moieties can donate electrons or form complexes with metal ions [38], facilitating redox reactions. The aromatic and quinone‐like structures are associated with free‐radical scavenging and electron transfer capabilities [39], whereas aliphatic components and polysaccharide linkages enhance binding affinity and stability in biological systems [40]. These combined functional features provide a mechanistic explanation for Shilajit's reported antioxidant, anti‐inflammatory, and adaptogenic activities, which are attributed to its humic‐derived constituents.
The GC‐MS profiling of Shilajit across solvents revealed a broad chemical spectrum reflecting its complex organic‐mineral composition and the diverse solubility of its constituents. Solvent polarity and derivatization clearly influenced the qualitative and quantitative detection of metabolites, with each extract class revealing unique chemical subsets. Methanol and ethyl acetate, being polar and moderately polar solvents, extracted numerous oxygenated aromatics, phenolic acids, aldehydes, and flavonoids, while hexane primarily recovered long‐chain fatty acids and nonpolar aliphatic compounds. The acetonitrile extract, particularly after BSTFA + TMCS derivatization, exposed a higher diversity of semi‐volatile metabolites including alkaloids, terpenoids, and steroidal structures that were otherwise undetectable in underivatized samples. This demonstrates that multi‐solvent extraction combined with derivatization provides a more comprehensive metabolomic window into Shilajit, capturing both polar and lipophilic components.
The consistent presence of benzoic acid across all solvent extracts suggests that it is a core chemical marker of Shilajit's organic matrix. Benzoic acid is known to originate from the oxidative degradation of lignin‐ and polyphenol‐derived humic precursors [41] and remains one of the most thermally stable low‐molecular‐weight aromatics. Its repeated detection across polar and nonpolar extracts likely reflects both its true chemical abundance and its high GC‐MS compatibility. It is also possible that a portion of the detected benzoic acid arises from thermal decomposition of phenolic precursors during GC‐MS analysis but this remains speculative and would require dedicated degradation studies to confirm. Literature surveys also report the consistent detection of benzoic acid in Shilajit samples collected from various geographical regions [42], supporting its role as a universally occurring constituent. Benzoic acid acts as an antimicrobial and antifungal agent by disrupting microbial metabolism at low pH [43]. It also shows antioxidant, anti‐inflammatory [44], and antiviral properties [45], and is used in food preservation and dermatological treatments.
The appearance of fatty acids such as palmitic, stearic, and oleic acid across several extracts indicates the contribution of lipid‐derived components to the overall chemical complexity of Shilajit. These long‐chain fatty acids, commonly found in plant resins and microbial biofilms, may participate in membrane‐modulating or anti‐inflammatory activities [46]. Morin is a potent antioxidant flavonoid with anti‐inflammatory, antidiabetic, anticancer, and cardioprotective effects. It protects cells from oxidative stress and exhibits antimicrobial and liver‐protective properties [47]. Other Flavonoids like epigallocatechin and phenolic acids (3‐hydroxybenzoic, 4‐hydroxybenzoic) further expand the antioxidant profile of the material, supporting earlier reports of its free‐radical‐scavenging capacity [48]. Gallic acid, a natural phenolic acid with strong antioxidant, anti‐inflammatory, antimicrobial, and anticancer effects. It also offers neuroprotective and anti‐obesity benefits [49].
The occurrence of terpenoids and sesquiterpenoids such as isopulegol, germacrone, and cryptomeridiol (Table 4) aligns with the resinous and plant‐derived origin of Shilajit. Isopulegol, a monoterpene alcohol, exhibits notable anti‐inflammatory, gastroprotective, and neuroprotective activities, along with antibacterial, antifungal, and antiviral effects [50]. Cryptomeridiol, a sesquiterpenoid alcohol, demonstrates antioxidant, antimicrobial, anti‐inflammatory, and melanin‐inhibiting properties which indicates the potential applications in the treatment of pigmentation disorders and certain cancers [51]. Germacrone, another sesquiterpenoid primarily found in plants of the Zingiberaceae family, possesses anticancer, anti‐inflammatory, antiviral, and neuroprotective properties, and exhibits insecticidal, antimicrobial, and hepatoprotective effects [52]. The presence of these bioactive compounds suggests their formation as secondary metabolites during the prolonged humification and diagenetic transformation of plant and resinous organic matter.
The RF was especially rich in simple esters, carboxylic acids, phenolics, flavanols, and sterol derivatives (Table 5), underscoring its chemical activity and compatibility with GC‐MS detection. Notably, the application of a GC‐MS‐focused approach to the RF represents a novel analytical strategy, enabling the identification of a wider range of low‐molecular‐weight constituents than previously reported for Shilajit. The predominance of these small, bioactive compounds correlates with the stronger antibacterial activity observed in vitro, suggesting that the biological efficacy of Shilajit is driven primarily by its low‐molecular‐weight phenolic and aromatic acids rather than by its macromolecular humic matrix.
Overall, these results illustrate that Shilajit is a multicomponent natural system containing both polar phenolic acids and lipophilic fatty or terpenoid molecules, each contributing differently to its biological effects. The repeated detection of benzoic points to these as potential chemical markers for quality control and pharmacological standardization. The complementary nature of solvent extraction and derivatization highlights the necessity of multi‐technique analytical approaches to capture the complete chemical complexity of humic‐resinous substances like Shilajit. Future work should include targeted quantification of major aromatic acids, LC‐MS and NMR confirmation of the steroidal and alkaloidal compounds, and correlation of specific metabolites with bioassay outcomes to establish a definitive structure–activity relationship.
SEM micrographs of dry Shilajit sample revealed irregular, fractured particles with heterogeneous morphology. At lower magnifications, rough, angular aggregates (Figure 4a,b) indicated incomplete mixing of organic and mineral components. In contrast, higher magnification of 5000x and 10 000x (Figure 4c,d) shows layered, porous, and sheet‐like textures typical of humic and fulvic substances, showing strong similarity with previously reported SEM features of Shilajit [3, 53]. The presence of cracks and folds suggests a brittle and compact structure formed during natural decomposition and mineral association. The rough, angular morphology may also result from the presence of mineral elements such as Ca, Mg, and Si which are detected in EDX, which contribute to surface hardness and structural irregularity.
EDX analysis confirmed the predominantly organic nature of Shilajit, with carbon and oxygen as major constituents and minor amounts of Na, Mg, Si, S, Cl, K, and Ca forming the mineral fraction (Table 6). Notably, no toxic heavy metals such as Pb, Cd, Hg, or As were detected in the EDX spectra of the analyzed Shilajit sample, suggesting the absence of gross heavy‐metal contamination within the detection limits of the technique. The elemental diversity observed in this study aligns with previous ICP‐MS and EDX findings that link Shilajit's essential mineral profile to its reported bioactivity [5, 42, 54]. The dominance of C and O corresponds with FTIR peaks of oxygenated functional groups, while SEM micrographs showing irregular, heterogeneous morphology support the organic‐mineral matrix. Overall, the EDX data suggest that Shilajit mainly comprises carbonaceous organic matter associated with small quantities of mineral elements.
The ADMET assessment of 36 Shilajit‐derived compounds (Table S2) demonstrated that a majority (over 80%) possess strong gastrointestinal absorption, while approximately half exhibit the ability to penetrate the blood‐brain barrier (Figure 6), particularly smaller, lipophilic molecules such as benzoic acid, benzamide, and fenchone. Most compounds satisfied Lipinski's rule of five, suggesting favorable oral bioavailability. Phenolic and carboxylic derivatives showed moderate polarity and solubility, properties often associated with antioxidant, antibacterial, and antifungal effects. In contrast, a few bulky lipophilic constituents displayed lower solubility yet may enhance membrane interaction or contribute to sustained biological activity. The lack of CYP450 inhibition and PAINS alerts indicates a minimal risk of metabolic toxicity or false‐positive screening. As ADMET predictions for Shilajit constituents have rarely been reported, direct comparisons with earlier literature are limited. However, the current dataset provides one of the most comprehensive ADMET profiles for Shilajit to date. Collectively, the ADMET profile underscores the chemical diversity of Shilajit and provides preliminary insight into the potential pharmacokinetic behavior and drug‐likeness of its identified constituents. However, these findings are based solely on computational predictions and require further experimental validation to confirm biological and pharmacological relevance.
The RF exhibited substantially higher antibacterial activity than whole Shilajit. This enhanced activity can be attributed to the presence of benzoic acid, gallic acid, and their related derivatives, which are known to serve as key antibacterial constituents. The high abundance of benzoic acid in RF likely plays a central role by lowering intracellular pH and destabilizing bacterial membranes [43], while additional molecules such as terpenoids (germacrone, isopulegol), simple esters, and fatty acids may contribute synergistically. The enhanced activity of RF compared to polymer‐rich humic/fulvic fractions indicates that fractionation concentrates small, membrane‐permeable, ADMET‐favorable metabolites that are more effective at bacterial entry.
Quantitative MIC assessment further supported the antibacterial trends observed in agar‐based assays, with the residual fraction (RF) exhibiting lower MIC values against B. cereus and P. aeruginosa than whole Shilajit, indicating enhanced antibacterial potency following fractionation. Although the observed activity was lower than that typically reported for standard antibacterial and antifungal drugs, such moderate activity is expected for crude natural fractions rather than purified antimicrobial compounds. Nevertheless, the lower MIC values observed for RF against B. cereus and P. aeruginosa indicate the presence of biologically relevant antibacterial constituents that may contribute to the traditional therapeutic significance of Shilajit. In contrast, both RF and Shilajit displayed comparatively high or undetectable MIC values against filamentous fungi, consistent with the mild antifungal activity observed in diffusion assays. This weaker antifungal response may be attributed to the thick, chitin‐rich fungal cell wall and reduced membrane permeability, which limit the penetration of acidic and moderately polar compounds, as well as the apparent absence of potent fungus‐specific secondary metabolites in the tested fractions. Overall, the antimicrobial profile suggests a predominantly bacteriostatic effect mediated by phenolic acids and aromatic constituents, while antifungal efficacy remains limited.
5. Conclusion
The present study employed an integrated chemical and biological framework to deconstruct the complex matrix of Himalayan Shilajit, moving beyond from traditional characterization to identify specific bioactive fractions. Sequential fractionation followed by FTIR, GC‐MS, and SEM‐EDS analyses enabled a comprehensive evaluation of its chemical and structural diversity. FTIR confirmed successful fractionation by revealing clear shifts in functional group distribution, particularly the enrichment of phenolic and oxygenated groups associated with antioxidant potential, with all fractions showing similarity to humic substances reported in earlier studies. Notably, GC‐MS analysis revealed several previously unreported volatile and non‐volatile constituents in Shilajit and its fractions. SEM‐EDS analysis highlighted a heterogeneous, mineral‐poor microstructure dominated by C and O. ADMET evaluation of the 36 GC‐MS‐identified molecules demonstrated favorable drug‐likeness, further supporting their therapeutic relevance. Notably, the RF, enriched in benzoic acid, exhibited strong antibacterial activity comparable to standard antibiotics is a novel observation, as this fraction has not been previously explored for bioactivity. Nevertheless, definitive structural confirmation of GC‐MS‐identified compounds using advanced techniques such as NMR and high‐resolution LC‐MS, along with in vivo toxicokinetic evaluation and mechanistic antimicrobial studies, is required to fully validate their bioactivity. Overall, the findings advance the chemical understanding of Shilajit, dispel prevalent misconceptions, and introduce new bioactive leads for future pharmacological investigation.
6. Limitations and Future Perspectives
The present study primarily focused on the qualitative characterization and preliminary biological evaluation of Shilajit fractions. Compound identification was based mainly on GC‐MS spectral matching, and absolute quantification or structural confirmation using advanced analytical techniques such as LC‐MS/MS and NMR was not performed. The ADMET assessment was limited to computational prediction and therefore requires experimental pharmacological and toxicological validation. In addition, antimicrobial evaluation was conducted against selected microbial strains only, and cytotoxicity or hemolysis assays were not included in the current investigation. Future studies involving targeted metabolite quantification, mechanistic analysis, toxicity evaluation, broader antimicrobial screening, and advanced structural characterization will further strengthen the understanding of Shilajit and its bioactive constituents.
Author Contributions
Dr. M. David designed, supervised, coordinated the entire study, and played an active role in technical and data reviewing and drafting the manuscript. Sujit Mallappa Karalatti conducted all experimental procedures, including analytical and characterization work, as well as data processing and statistical evaluations. Both authors were actively involved in the research and have approved the final version of the manuscript.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Supporting File 1: cbdv71551‐sup‐0001‐FigureS1‐S5.docx
Supporting File 2: cbdv71551‐sup‐0002‐TableS1‐S2.docx
Acknowledgments
The primary author is thankful to the Council of Scientific and Industrial Research (CSIR) for providing Junior Research Fellowship (File No: 09/0101(19655)/2024‐EMR‐I). Authors also acknowledge the University Scientific Instrumentation Facility, Karnatak University, Dharwad for providing the FTIR facility. Authors also acknowledge the SAIF Karnatak University, Dharwad for providing GC‐MS, SEM‐EDS facility.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Khanna R., Witt M., Anwer Md K., et al., “Spectroscopic Characterization of Fulvic Acids Extracted From the Rock Exudate Shilajit,” Organic Geochemistry 39 (2008): 1719–1724, 10.1016/j.orggeochem.2008.08.009. [DOI] [Google Scholar]
- 2. Schepetkin I. A., Khlebnikov A. I., Ah S. Y., et al., “Characterization and Biological Activities of Humic Substances From Mumie,” Journal of Agricultural and Food Chemistry 51 (2003): 5245–5254, 10.1021/jf021101e. [DOI] [PubMed] [Google Scholar]
- 3. Agarwal S. P., Khanna R., Karmarkar R., et al., “Physico‐Chemical, Spectral, and Thermal Characterization of Shilajit, a Humic Substance With Medicinal Properties,” Asian Journal of Chemistry 20 (2008): 209. [Google Scholar]
- 4. Yaqoob Z., Batool S. A., Khan A., et al., “Characterization and Medicinal Applications of Karakoram Shilajit; Angiogenesis Activity, Antibacterial Properties, and Cytotoxicity,” Materials Research Express 10 (2023): 105403, 10.1088/2053-1591/ad04bd. [DOI] [Google Scholar]
- 5. Al‐Salman F., Redha A. A., and Al‐Zaimoor Z., “Inorganic Analysis and Antioxidant Activity of Shilajit,” Inorganic Analysis and Antioxidant Activity of Shilajit 7 (2020): 5–10. [Google Scholar]
- 6. Kamgar E., Spryszyńska A., Zembrzuska J., et al., “Plant‐Derived Phenolic Acids in Shilajit: A Comparative HPLC–MS/MS Analysis Across Five Regions,” Scientific Reports 16 (2026): 9268, 10.1038/s41598-026-40090-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Park J.‐S., Kim G.‐Y., and Han K., “The Spermatogenic and Ovogenic Effects of Chronically Administered Shilajit to Rats,” Journal of Ethnopharmacology 107 (2006): 349–353, 10.1016/j.jep.2006.03.039. [DOI] [PubMed] [Google Scholar]
- 8. Wilson E., Rajamanickam G. V., Dubey G. P., et al., “Review on Shilajit Used in Traditional Indian Medicine,” Journal of Ethnopharmacology 136 (2011): 1–9, 10.1016/j.jep.2011.04.033. [DOI] [PubMed] [Google Scholar]
- 9. Agarwal S. P., Khanna R., Karmarkar R., et al., “Shilajit: A Review,” Phytotherapy Research 21 (2007): 401–405, 10.1002/ptr.2100. [DOI] [PubMed] [Google Scholar]
- 10. Kishore K., Thakur S., and Chaudhary V. S., “A Literary Review on Shilajit,” IRJAY 06 (2023): 70–77, 10.47223/IRJAY.2023.6511. [DOI] [Google Scholar]
- 11. Meena H., Pandey H., Arya M., and Ahmed Z., “Shilajit: A Panacea for High‐Altitude Problems,” International Journal of Ayurveda Research 1 (2010): 37, 10.4103/0974-7788.59942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Carrasco‐Gallardo C., Guzmán L., and Maccioni R. B., “ Shilajit : A Natural Phytocomplex With Potential Procognitive Activity,” International Journal of Alzheimer's Disease 2012 (2012): 1–4, 10.1155/2012/674142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Elahi S., Sani A. M., and Sarabi‐Jamab M., “Physicochemical, Antioxidant, and Antimicrobial Characteristics of Two Types of Mumies(shilajit),” Food Measure 18 (2024): 4137–4146, 10.1007/s11694-024-02481-2. [DOI] [Google Scholar]
- 14. Pandit S., Biswas S., Jana U., et al., “Clinical Evaluation of Purified Shilajit on Testosterone Levels in Healthy Volunteers,” Andrologia 48 (2016): 570–575, 10.1111/and.12482. [DOI] [PubMed] [Google Scholar]
- 15. Stohs S. J., “Safety and Efficacy of Shilajit (Mumie, Moomiyo),” Phytotherapy Research 28 (2014): 475–479, 10.1002/ptr.5018. [DOI] [PubMed] [Google Scholar]
- 16. El‐Sayed M.‐I. K., Amin H.‐K., and Al‐Kaf A.‐G., “Anti‐Microbial, Anti‐Oxidant, and Anti‐Ulcerogenic Effects of Shilajit on Gastric Ulcer in Rats,” American Journal of Biochemistry and Biotechnology 8 (2012): 25–37. [Google Scholar]
- 17. Ali D. Q., “Evaluation of the Antibacterial Activity of Shilajit Aqueous Extract on Clinically Isolated Bacteria in Kalar District,” Iraqi Journal of Medical Sciences 28 (2024): 320–329, 10.32792/jmed.v28i2.588. [DOI] [Google Scholar]
- 18. Shadab M. and Pant K., “Study on Antimicrobial Properties of UV Treated Shilajit,” International Journal of Toxicological and Pharmacological Research (IJTPR) 5 (2013): 1–4. [Google Scholar]
- 19. Mishra T., Sircar D., Dhaliwal H. S., and Singh N., “Spectroscopic and Chromatographic Characterization of Crude Natural Shilajit From Himachal Pradesh, India,” NPJ 10 (2020): 244–256, 10.2174/2210315509666190112111808. [DOI] [Google Scholar]
- 20. Savchyna L. A., Kozyatnyk I. P., Poliakova T. V., and Klymenko N. A., “Influence of Surface Chemistry and Structure of Activated Carbon on Adsorption of Fulvic Acids From Water Solution,” Water Science and Technology 60 (2009): 441–447, 10.2166/wst.2009.344. [DOI] [PubMed] [Google Scholar]
- 21. Jernain N. and Muniswamy D., “Phyto‐Fabrication of Silver Nanoparticles Using Swietenia Macrophylla Seed Extract and Its InVitro Antidiabetic Activity,” in Proceedings of International Conference on Drug Discovery (ICDD, 2020): Available at SSRN: https://ssrn.com/abstract=3533755. [Google Scholar]
- 22. Swamy M. K., Arumugam G., Kaur R., et al., “GC‐MS Based Metabolite Profiling, Antioxidant, and Antimicrobial Properties of Different Solvent Extracts of Malaysian Plectranthus amboinicus Leaves,” Evidence‐Based Complementary and Alternative Medicine (2017): 1517683, 10.1155/2017/1517683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Mohd M. A., Advanced Gas Chromatography: Progress in Agricultural, Biomedical and Industrial Applications, BoD–Books on Demand. [Google Scholar]
- 24. Daina A., Michielin O., and Zoete V., “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug‐Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7 (2017): 42717, 10.1038/srep42717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Balouiri M., Sadiki M., and Ibnsouda S. K., “Methods for In Vitro Evaluating Antimicrobial Activity: A Review,” Journal of Pharmaceutical Analysis 6 (2016): 71–79, 10.1016/j.jpha.2015.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Arnesen L. P. S., Fagerlund A., and Granum P. E., “From Soil to Gut: Bacillus cereus and Its Food Poisoning Toxins,” FEMS Microbiology Review 32 (2008): 579–606, 10.1111/j.1574-6976.2008.00112.x. [DOI] [PubMed] [Google Scholar]
- 27. Latgé J.‐P., “ Aspergillus fumigatus and Aspergillosis,” Clinical Microbiology Reviews 12 (1999): 310–350, 10.1128/CMR.12.2.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically (Clinical and Laboratory Standards Institute, 2018). [Google Scholar]
- 29. Khadraoui N., Kallel K., Bouchami O., et al., “PFGE Types of Candida tropicalis Isolates From an Intensive Care Unit in a Tunisian Hospital,” Journal de Mycologie Médicale 20 (2010): 169–173, 10.1016/j.mycmed.2010.05.003. [DOI] [Google Scholar]
- 30. Coates J., “Interpretation of Infrared Spectra, a Practical Approach,” in Encyclopedia of Analytical Chemistry, 1st ed., ed. Meyers R. A., (Wiley, 2000). [Google Scholar]
- 31. Campitelli P. and Ceppi S., “Effects of Composting Technologies on the Chemical and Physicochemical Properties of Humic Acids,” Geoderma 144 (2008): 325–333, 10.1016/j.geoderma.2007.12.003. [DOI] [Google Scholar]
- 32. Perez M. G., Martin‐Neto L., Saab S. C., et al., “Characterization of Humic Acids From a Brazilian Oxisol Under Different Tillage Systems by EPR, 13C NMR, FTIR and fluorescence spectroscopy,” Geoderma 118, no. 3‐4 (2004): 181–190, 10.1016/S0016-7061(03)00192-7. [DOI] [Google Scholar]
- 33. Niemeyer J., Chen Y., and Bollag J.‐M., “Characterization of Humic Acids, Composts, and Peat by Diffuse Reflectance Fourier‐Transform Infrared Spectroscopy,” Soil Science Society of America 56 (1992): 135–140, 10.2136/sssaj1992.03615995005600010021x. [DOI] [Google Scholar]
- 34. Elkins K. M. and Nelson D. J., “Fluorescence and FT‐IR Spectroscopic Studies of Suwannee River Fulvic Acid Complexation With Aluminum, Terbium, and Calcium,” Journal of Inorganic Biochemistry 87 (2001): 81–96, 10.1016/S0162-0134(01)00318-X. [DOI] [PubMed] [Google Scholar]
- 35. Fu H. and Quan X., “Complexes of Fulvic Acid on the Surface of Hematite, Goethite, and Akaganeite: FTIR Observation,” Chemosphere 63 (2006): 403–410, 10.1016/j.chemosphere.2005.08.054. [DOI] [PubMed] [Google Scholar]
- 36. Stevenson F. J., Humus Chemistry: Genesis, Composition, Reactions (Wiley, 1994). [Google Scholar]
- 37. Tatzber M., Stemmer M., Spiegel H., et al., “FTIR‐Spectroscopic Characterization of Humic Acids and Humin Fractions Obtained by Advanced NaOH, Na4P2O₇, and Na2CO3 Extraction Procedures,” Journal of Plant Nutrition and Soil Science 170 (2007): 522–529. [Google Scholar]
- 38. Saar R. A. and Weber J. H., “Fulvic Acid: Modifier of Metal‐ion Chemistry,” Environmental Science & Technology 16 (1982): 510A–517A, 10.1021/es00103a723. [DOI] [PubMed] [Google Scholar]
- 39. Aeschbacher M., Graf C., Schwarzenbach R. P., and Sander M., “Antioxidant Properties of Humic Substances,” Environmental Science & Technology 46 (2012): 4916–4925, 10.1021/es300039h. [DOI] [PubMed] [Google Scholar]
- 40. Elkins K. M. and Nelson D. J., “Spectroscopic Approaches to the Study of the Interaction of Aluminum With Humic Substances,” Coordination Chemistry Reviews 228 (2002): 205–225, 10.1016/S0010-8545(02)00040-1. [DOI] [Google Scholar]
- 41. Zhong X., Cui C., and Yu S., “Formation of Aldehydes and Carboxylic Acids in Humic Acid Ozonation,” Water, Air, & Soil Pollution 228 (2017): 229, 10.1007/s11270-017-3418-1. [DOI] [Google Scholar]
- 42. Rawat H., Singh R., Dane G., et al., “Exploring the Geographical Variability of Asphaltum Punjabianum (Shilajit) From India in Elements and Phytochemicals Variations Using GC–MS/MS, LC, ICP OES, and In‐Silico Studies,” Results in Chemistry 10 (2024): 101691, 10.1016/j.rechem.2024.101691. [DOI] [Google Scholar]
- 43. Krebs H. A., Wiggins D., Stubbs M., et al., “Studies on the Mechanism of the Antifungal Action of Benzoate,” Biochemical Journal 214 (1983): 657–663, 10.1042/bj2140657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Franck⁎ T., Ghitti G., Mouithys‐Mickalad A., et al., “Antioxidant and Anti‐inflammatory Like Properties of Benzoic Acid Analogs on the Oxidant Response of Neutrophils: Structure/Redox Potential Relationship Study,” Free Radical Biology and Medicine 53 (2012): S112–S113, 10.1016/j.freeradbiomed.2012.08.236. [DOI] [Google Scholar]
- 45. Strand M., Islam K., Edlund K., et al., “2‐[4,5‐Difluoro‐2‐(2‐Fluorobenzoylamino)‐Benzoylamino]Benzoic Acid, an Antiviral Compound With Activity Against Acyclovir‐Resistant Isolates of Herpes Simplex Virus Types 1 and 2,” Antimicrobial Agents and Chemotherapy 56 (2012): 5735–5743, 10.1128/AAC.01072-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Kawaguchi K., Nakagawa K. M., Nakagawa S., et al., “Conformation of Ultra‐Long‐Chain Fatty Acid in Lipid Bilayer: Molecular Dynamics Study,” Journal of Chemical Physics 153 (2020): 165101, 10.1063/5.0026030. [DOI] [PubMed] [Google Scholar]
- 47. Mottaghi S. and Abbaszadeh H., “The Anticarcinogenic and Anticancer Effects of the Dietary Flavonoid, Morin: Current Status, Challenges, and Future Perspectives,” Phytotherapy Research 35 (2021): 6843–6861, 10.1002/ptr.7270. [DOI] [PubMed] [Google Scholar]
- 48. Capasso L., De Masi L., Sirignano C., et al., “Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities, and Therapeutic Potential,” Molecules 30 (2025): 654, 10.3390/molecules30030654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Bai J., Zhang Y., Tang C., et al., “Gallic Acid: Pharmacological Activities and Molecular Mechanisms Involved in Inflammation‐Related Diseases,” Biomedicine & Pharmacotherapy 133 (2021): 110985, 10.1016/j.biopha.2020.110985. [DOI] [PubMed] [Google Scholar]
- 50. Ramos A. G. B., De Menezes I. R. A., and Da Silva M. S. A., “Antiedematogenic and Anti‐Inflammatory Activity of the Monoterpene Isopulegol and Its β‐Cyclodextrin (β‐CD) Inclusion Complex in Animal Inflammation Models,” Foods 9 (2020): 630, 10.3390/foods9050630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Kumar R. V., Gosipatala S. B., and Kumar R., “Characterization, Antioxidant, and Antimicrobial Properties of Mulberry Lattices,” ACS Omega 8 (2023): 47758–47772, 10.1021/acsomega.3c06069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Riaz A., Rasul A., Kanwal N., et al., “Germacrone: A Potent Secondary Metabolite With Therapeutic Potential in Metabolic Diseases, Cancer, and Viral Infections,” CDM 21 (2020): 1079–1090, 10.2174/1389200221999200728144801. [DOI] [PubMed] [Google Scholar]
- 53. Basavaraja D., Katkar R., and Dhaka P., “Chemical Analysis of Native Himalayan Shilajit: An Evaluation of an Ayurvedic Formulation,” ACS Omega Acsomega (2025), 57097–57106, 10.1021/acsomega.5c05533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Aldakheel R. K., Gondal M. A., Alsayed H. N., et al., “Rapid Determination and Quantification of Nutritional and Poisonous Metals in Vastly Consumed Ayurvedic Herbal Medicine (Rejuvenator Shilajit) by Humans Using Three Advanced Analytical Techniques,” Biological Trace Element Research 200 (2022): 4199–4216, 10.1007/s12011-021-03014-4. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting File 1: cbdv71551‐sup‐0001‐FigureS1‐S5.docx
Supporting File 2: cbdv71551‐sup‐0002‐TableS1‐S2.docx
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
